CSNpharm
Auxinole is a potent auxin antagonist of TIR1/AFB receptors, binding TIR1 to block the formation of the TIR1-IAA-Aux/IAA complex and so inhibits auxin-responsive gene expression.
More Information
Supplier Page
CSNpharm
Auxinole is a potent auxin antagonist of TIR1/AFB receptors, binding TIR1 to block the formation of the TIR1-IAA-Aux/IAA complex and so inhibits auxin-responsive gene expression.
More Information
Supplier Page
CSNpharm
Auxinole is a potent auxin antagonist of TIR1/AFB receptors, binding TIR1 to block the formation of the TIR1-IAA-Aux/IAA complex and so inhibits auxin-responsive gene expression.
More Information
Supplier Page
CSNpharm
AV-153 free base, a 1,4-dihydropyridine (1,4-DHP) derivative, is an antimutagenic. AV-153 free base intercalates to DNA in a single strand break and reduces DNA damage, stimulates DNA repair in human cells in vitro. AV-153 free base interacts with thymine and cytosine and has an influence on poly(ADP)ribosylation. AV-153 free base has anti-cancer activity.
More Information
Supplier Page
CSNpharm
Avanafil is a potent and highly selective phosphodiesterase-5 (PDE-5) inhibitor with IC50 of 5.2 nM for erectile dysfunction, exhibiting lower selectivity against PDE1, PDE6, and PDE11.
More Information
Supplier Page
CSNpharm
Avanafil is a potent and highly selective phosphodiesterase-5 (PDE-5) inhibitor with IC50 of 5.2 nM for erectile dysfunction, exhibiting lower selectivity against PDE1, PDE6, and PDE11.
More Information
Supplier Page
CSNpharm
Avanafil is a potent and highly selective phosphodiesterase-5 (PDE-5) inhibitor with IC50 of 5.2 nM for erectile dysfunction, exhibiting lower selectivity against PDE1, PDE6, and PDE11.
More Information
Supplier Page
CSNpharm
Avasimibe is an ACAT inhibitor with IC50 of 3.3 μM, it also inhibits human P450 isoenzymes CYP2C9, CYP1A2 and CYP2C19 with IC50 of 2.9/13.9 and 26.5 μM, respectively.
More Information
Supplier Page
CSNpharm
Avasimibe is an ACAT inhibitor with IC50 of 3.3 μM, it also inhibits human P450 isoenzymes CYP2C9, CYP1A2 and CYP2C19 with IC50 of 2.9/13.9 and 26.5 μM, respectively.
More Information
Supplier Page
CSNpharm
Avasimibe is an ACAT inhibitor with IC50 of 3.3 μM, it also inhibits human P450 isoenzymes CYP2C9, CYP1A2 and CYP2C19 with IC50 of 2.9/13.9 and 26.5 μM, respectively.
More Information
Supplier Page
CSNpharm
Avasimibe is an ACAT inhibitor with IC50 of 3.3 μM, it also inhibits human P450 isoenzymes CYP2C9, CYP1A2 and CYP2C19 with IC50 of 2.9/13.9 and 26.5 μM, respectively.
More Information
Supplier Page
CSNpharm
Avasimibe is an ACAT inhibitor with IC50 of 3.3 μM, it also inhibits human P450 isoenzymes CYP2C9, CYP1A2 and CYP2C19 with IC50 of 2.9/13.9 and 26.5 μM, respectively.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Avibactam free acid is a covalent, reversible β-lactamase inhibitor, and inhibits β-lactamase TEM-1 and CTX-M-15 with IC50 of 8 nM and 5 nM, respectively.
More Information
Supplier Page
CSNpharm
Avibactam free acid is a covalent, reversible β-lactamase inhibitor, and inhibits β-lactamase TEM-1 and CTX-M-15 with IC50 of 8 nM and 5 nM, respectively.
More Information
Supplier Page
CSNpharm
Avibactam free acid is a covalent, reversible β-lactamase inhibitor, and inhibits β-lactamase TEM-1 and CTX-M-15 with IC50 of 8 nM and 5 nM, respectively.
More Information
Supplier Page
CSNpharm
Avibactam free acid is a covalent, reversible β-lactamase inhibitor, and inhibits β-lactamase TEM-1 and CTX-M-15 with IC50 of 8 nM and 5 nM, respectively.
More Information
Supplier Page
CSNpharm
Avibactam free acid is a covalent, reversible β-lactamase inhibitor, and inhibits β-lactamase TEM-1 and CTX-M-15 with IC50 of 8 nM and 5 nM, respectively.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
AWD 131-138 is a partial agonist of benzodiazepine receptor with effective anticonvulsant and anxiolytic properties.
More Information
Supplier Page
CSNpharm
AWD 131-138 is a partial agonist of benzodiazepine receptor with effective anticonvulsant and anxiolytic properties.
More Information
Supplier Page
CSNpharm
AWD 131-138 is a partial agonist of benzodiazepine receptor with effective anticonvulsant and anxiolytic properties.
More Information
Supplier Page
CSNpharm
AWD 131-138 is a partial agonist of benzodiazepine receptor with effective anticonvulsant and anxiolytic properties.
More Information
Supplier Page
CSNpharm
AWD 131-138 is a partial agonist of benzodiazepine receptor with effective anticonvulsant and anxiolytic properties.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Axitinib is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM in Porcine aorta endothelial cells, respectively.
More Information
Supplier Page
CSNpharm
Axitinib is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM in Porcine aorta endothelial cells, respectively.
More Information
Supplier Page
CSNpharm
Ayanin, a natural product isolated and purified from the rhizomes of Curcuma aromatica, with vasorelaxant activity and may have the potential for use in treating allergic asthma. Its IC(50) value 2.2mM for inhibiting interleukin (IL)-4 production from purified basophils.
More Information
Supplier Page
CSNpharm
Ayanin, a natural product isolated and purified from the rhizomes of Curcuma aromatica, with vasorelaxant activity and may have the potential for use in treating allergic asthma. Its IC(50) value 2.2mM for inhibiting interleukin (IL)-4 production from purified basophils.
More Information
Supplier Page
AZ 33
1mg
| ≥99%
CSNpharm
AZ 33
100mg
| ≥99%
CSNpharm
AZ 33
50mg
| ≥99%
CSNpharm
AZ 33
5mg
| ≥99%
CSNpharm
AZ 33
10mg
| ≥99%
CSNpharm
AZ32
25mg
| ≥99%
CSNpharm
AZ32
5mg
| ≥99%
CSNpharm
AZ32
1mg
| ≥99%
CSNpharm
AZ32
100mg
| ≥99%
CSNpharm
